Michael Lincoff, Cleveland Clilnic, Cleveland Ohio American College of Cardiology Annual Scientific Session March 11-14, 2006, Atlanta
The full picture of how bivalirudin is emerging as a treatment without also using glycoprotein IIb/IIIa inhibition in cases of acute coronary syndrome was painted at the Atlanta meeting by Michael Lincoff from the Cleveland Clinic.
Gregg Stone, Columbia University Medical Center, New York
American College of Cardiology Annual Scientific Session March 11-14, 2006, Atlanta
A superiority for
Post a comment